Unilateral surgically induced Necrotizing Scleritis after trabeculectomy with Ologen in a patient with pigmentary glaucoma  by Shalaby, Usama & Heikal, Mohamed Amin
lable at ScienceDirect
American Journal of Ophthalmology Case Reports 3 (2016) 47e49Contents lists avaiAmerican Journal of Ophthalmology Case Reports
journal homepage: http : / /www.ajocasereports .com/Case reportUnilateral surgically induced Necrotizing Scleritis after
trabeculectomy with Ologen in a patient with pigmentary glaucoma*
Usama Shalaby, Mohamed Amin Heikal*
Benha University, Department of Ophthalmology, Benha, Qalyubia, Egypta r t i c l e i n f o
Article history:
Received 29 January 2016
Accepted 13 June 2016
Available online 27 June 2016
Keywords:
Necrotizing Scleritis
Ologen
Pigmentary glaucoma
Trabeculectomy* The study was performed in Benha Ophthalm
Benha, Egypt.
* Corresponding author.
E-mail address: mohammedheikel@gmail.com (M
http://dx.doi.org/10.1016/j.ajoc.2016.06.005
2451-9936/© 2016 The Authors. Published by Elseviera b s t r a c t
Purpose: In this report we record the ﬁrst surgically induced Necrotizing Scleritis case related to tra-
beculectomy with the use of Ologen Collagen Matrix Implant.
Observations: Surgically induced Necrotizing Scleritis is a rare pathological entity that complicates ocular
(sclera) surgery.
Conclusions and importance: Prompt management of surgically induced Necrotizing Scleritis related to
trabeculectomy with the use of Ologen and close follow up is very important to prevent its destructive
nature on the globe.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Necrotizing Scleritis is a potentially destructive inﬂammatory
process that may be the presenting sign of severe systemic disease,
previous ocular trauma, or ocular infection.1 Surgically Induced
Necrotizing Scleritis (SINS) is a severe form of scleritis with a real
risk of globe distortion and ocular structure complications. Pigment
dispersion syndrome and pigmentary glaucoma are characterized
by accumulation of pigment on the central corneal endothelium as
well as trabeculum epithelium.2 Management of pigmentary
glaucoma is either by topical antiglaucoma drops, laser trabeculo-
plasty and trabeculectomy. Ologen is a porcine extracellular matrix
made of atelocollagen cross-linked with glycosaminoglycan.3 It is a
new alternative to traditional antimetabolites in glaucoma ﬁltra-
tion procedures. The biodegradable scaffolding matrix induces a
regenerative wound healing process without the need for anti-
ﬁbrotic agents.32. Case report
A 39 years old woman was discovered recently to have bilateral
advanced glaucoma due to pigment dispersion syndrome. She was
planned to have bilateral trabeculectomy due to advanced opticic Centre, Benha Univesity,
.A. Heikal).
Inc. This is an open access article unerve head cupping andmarked visual ﬁeld constriction. Subscleral
trabeculectomy with intraoperative mitomycin-C (MMC) applica-
tion was performed to right eye. Left eye was followed after one
week with trabeculectomy surgery with insertion of Ologen™
(Optous, Roseville, California).
Postoperatively intraocular pressure (IOP) went down to
8 mmHG (OD) and 6 mmHG (OS) and best corrected visual acuity
was 6/18 (OD) and 6/12 (OS). The visionwas low and nearly tubular
with advanced visual ﬁeld loss due to the delay in presentation of
the case. Three weeks later the lady developed sudden and severe
agonizing pain in her left eye (prevented the patient from sleeping).
The vision decreased to 6/36 with photophobia and difﬁculty in
opening her left eye. IOP was 10 mmHg (OS) and there was marked
injection and vascularization involving sclera, episclera and con-
junctiva in the trabeculectomy site. Ologen disappeared with an
area of 11  6 mm of sclera partially dissolved and choroid has
shown through (Fig. 1A). The left pupil was peaked up and refrac-
tion has markedly changed from 3.5 DC to 10 DC. There was no
conjunctival discharge and the anterior chamber was clear as well
as the cornea. There was no fundus changes (clear vitreous and no
retinal or choroidal exudations). Left conjunctival swabs were
taken for gram staining and cultures. Conjunctival and Tenon
debridement were taken for histopathology. Serological tests for
autoimmune diseases were done (RF, ANCA, ANA and anti-
phospholipid antibodies). SINS was given as a Provisional diagnosis
for the case based upon the certainty of being scleritis in the scene
of surgical trauma and the absence of signs of infection. Intra
venous methyl prednisolone (MP) pulse dose was givennder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. A: View of Surgically Induced Necrotizing Scleritis (OS) 3 weeks Post Trabeculectomy, showing hyperemia, vascularity & choroidal exposure 11 mm *4 mm. B: Sclera, 2 weeks
post treatment with diminution of inﬂammatory signs. C: Quitter eye with starting of healing process. D: About 50% of sclera covered with new collagen.
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repeated for another two days). The patient started to feel a rapid
improvement and she managed to sleep in the ﬁrst post infusion
night. Topical cyclopentolate 1% T.I.D; oral tetracycline and vitamin
C both of 1 gm daily dose were given as an adjunctive for the
treatment. After ﬁnishing MP doses, oral prednisolone (1 mg/kg
bodyweight) and cyclosporin-A (5mg/kg bodyweight) were added
to the treatment regimen (CBC with differential, kidney function
tests and FBS and postprandial were done before commencing the
treatment). Serological tests for autoimmune diseases were nega-
tive. Gram stains were negative for bacterial growth. The histopa-
thology yielded no growth as well as the cultured materials the
second week of incubation. Pain has disappeared on the second
post-treatment day and vision started to improve (reached the
early postoperative level, 6/12, after 3 weeks) and refraction
decreased to 5 DC. Slit lamp examination revealed marked
reduction in scleral vascularization and translucency and healing
started to be noticed as about 50% of the ulcerated sclera was
covered with new collagen and other extracellular matrices (Fig. 1;
B, C and D). Follow up plan is to stay on oral prednisolone and
cyclosporine but with gradual withdrawal of the former and
observation of sclera response. Scleral defect will be assessed after
complete subsidence of inﬂammation and deciding if the defect
needs graft or not. No evidence of scleritis was present in the right
eye at the same time.3. Discussion
Necrotizing scleritis (NS) is a severe form of scleral inﬂamma-
tion which causes scleral necrosis, ulceration and exposure of the
underlying uvea. NS is frequently associated with, autoimmune
diseases (such as poorly controlled RA or a systemic vasculitis),
infectious diseases and post ocular surgeries (SINS).
SINS have been recognized in post retinal detachment (RD),
strabismus, pterygium, penetrating keratoplasty and glaucoma
surgeries.4 The chance of scleritis increases with the use of anti-
metabolites, such as MMC and 5-FU in pterygium excision andsubscleral trabeculectomy operations. It appears that the scleritis is
initiated by surgical trauma to the sclera which in turn releases
circulating immune complexes that become precipitated in and
around the vessel walls in the area of insult.3 The diagnosis of SINS
in our case was mainly based on the following ﬁndings: 1- Devel-
opment of necrotizing scleritis in the scene of previous surgical
injury in the presence of foreign material (Ologen). 2- Absence of
signs (clinical or serological) of systemic autoimmune disease. 3-
Absence of signs (clinical or bacteriological) of infection. We
preferred to take a sample from the edge of the bleb for bacterio-
logical studies to exclude the infectious etiology in vicinity of
exposed intraocular tissues and we were on verge of giving sys-
temic steroids. In addition to the conjunctival swab, we took a very
small sample from the conjunctiva and from the episcleral tissues
with utmost care to avoid producing more insult to the already
inﬂamed sclera. Scleritis in this case could be due either directly to
surgical scleral injury or to the adverse reaction of Ologen. There is
a theoretical risk of increased inﬂammation in eyes with Ologen
implant as the implant is nonhuman (porcine) in origin.3 The
dissolution of Ologen in the case could be explained by, being tar-
geted by the inﬂammatory process and its exposure to proteolytic
enzymes, or its role as a foreign antigen that initiated the immune
reactions. No evidence of scleritis was present in the right eye at the
same time.
Reports in reconstructive surgery have shown an increased
inﬂammation with signs of foreign body reaction related to the
porcine cross-linked collagen implants when used in the repair of
experimental incisional hernia.5 There are no such reactions re-
ported when Ologen used in glaucoma surgeries.3 To the best of our
knowledge, this is the ﬁrst SINS case related to trabeculectomywith
the use of Ologen. More histopathological studies of the incised
sclera, episclera and conjunctiva in the presence of Ologen are
useful before a wide use of this material in the eye.Conﬂict of interest
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